Harry L.A. Janssen graduated from medical school in Nijmegen, Netherlands. During his study he spent one year as research fellow in Hepatology at the Mayo Clinic. He obtained his PhD at the Erasmus University in Rotterdam on the role of immune modulating therapy in chronic hepatitis B. Following his training in Internal Medicine in Leiden and Gastroenterology at the Erasmus University in Rotterdam, he returned to the Mayo Clinic for a Research Fellowship in Hepatology at the Center of Basic Research in Digestive Diseases.

Dr. Alexander Kuo is Professor of Medicine at Cedars-Sinai Medical Center. He serves as the Medical Director of Liver Transplantation and Program Director of the Transplant Hepatology Fellowship.

Dr. Gene Im is a transplant hepatologist and Director of the Alcohol-associated Liver Disease Program (ADAPT) at Columbia University, NY, USA. His clinical and research interests are in alcohol-associated liver disease, alcohol-associated hepatitis and liver transplantation. He is currently serving as the Vice Chair of the AASLD ALD SIG.

Dr. Michele Pritchard is a Professor at the University of Kansas Medical Center in Kansas City, KS studying how the stroma - extracellular matrix and non-parenchymal cells - regulates would repair and aging across tissue types, including the liver after alcohol exposure. In addition, Dr. Pritchard directs the Interdisciplinary Graduate Program in Biomedical Sciences at KUMC.

Dr. Tess Bittermann is a transplant hepatologist and epidemiologist. She recently transitioned from the University of Pennsylvania in Philadelphia to a joint position at the Royal Brisbane and Women's Hospital and the Queensland Institute for Medical Research in Brisbane, Australia. Her research focuses on the practice heterogeneity and understanding the comparative risks and benefits of immunosuppression strategies among transplant recipients and patients with autoimmune hepatitis.

Cristal Brown, MD, MHS is a transplant hepatologist and Assistant Professor of Medicine at the University of Texas at Austin Dell Medical School. As a physician-scientist, Dr. Brown focuses on interventions to help eliminate health disparities throughout the trajectory of end-stage liver disease.

Dr. Adnan Said is a Professor in the Division of Gastroenterology and Hepatology within the Department of Medicine at the University of Wisconsin (UW) School of Medicine and Public Health in Madison, WI. He also serves as program director of the UW Health Transplant hepatology Fellowship, Director of the UW Health Metabolic Liver Clinic and as Medical Director of the VA Liver Transplant Program.Dr.

Director, The Autoimmune and Rare Liver Disease Programme, and the Lily and Terry Horner Chair in Autoimmune Liver Disease Research, Division of Gastroenterology and Hepatology, Toronto General Hospital, Canada